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detection of critically ill patients. Most critical care patients
required mechanical ventilation and had a high case-fatality
rate.
PP-072 Comparative analysis of epidemiological and
clinical characteristics with mild and severe
inﬂuenza A (H1N1)
A.-R. Hu1 *, X.-Y. Liang1, W.Y. Xuan1, S.-W. Jiang1. 1Ningbo
Infectious Diseases Hospital, China
Objective: To comparatively analyze the epidemiological
and clinical characteristics of patients with severe
inﬂuenza A (H1N1).
Methods: The clinical data were analyzed retrospectively
from September 25, 2009 to November 23, 2009. Mild
patients were 33 cases and severe patients were 32 cases.
Results: Patients in the 2 groups were mainly young people.
The average age of mild group was 20.5±9.5 years old
vs 26.5±20.0 years old in severe group. Occupational
distribution of the 2 groups was mainly young staff and
students. Fever, cough, expectoration and fatigue were
prominent and characteristic features of the disease. The
ratio of hyperpyrexia (39ºC) and the duration of fever
were statistically signiﬁcant difference. There were no chest
tightness, shortness of breath and vomiting in mild group. All
patients in the 2 groups had throat congestion. No patients
in mild group had complication, 24 cases in severe group
had pneumonia and 8 cases had bronchial pneumonia. The
ratio of abnormal of WBC count and absolute neutrophil
count were statistically non-signiﬁcant difference, but the
abnormal of CK, LDH and liver function were statistically
signiﬁcant difference. All patients in severe group had
abnormal chest X-ray examinations vs normal in mild group.
All patients were successfully cured and discharged from
hospital by oseltamivir phosphate capsules, Chinese patent
medicine (Tanreqing injection) and symptomatic treatment.
There were statistically signiﬁcant difference of average
hospital stay in the 2 groups.
Conclusion: Patients with inﬂuenza A (H1N1) are mainly
young people. The complications of severe inﬂuenza A
(H1N1) are pneumonia, heart damage and liver function
abnormal and the process of the disease is in a extremely
dangerous state. Though the ratio is declining, early
detection, intensive care and active treatment should
be all the same taken. Traditional Chinese medicine has
comparative advantage and should be promoted.
PP-073 An analysis of the clinical features of A/H1N1
inﬂuenza infection
C.R. Zhang1 *, J.C. Lin1, M. Li1, H. Zhou1, W.L. Cui1. 1Huang
Pu Hospital of the First Afﬁliated Hospital, Sun Yat-sen
University, China
Objective: To reduce stuffs and patients being infected in
hospitals, the clinical features of A/H1N1 inﬂuenza infection
were studied.
Methods: The clinical data of 17 patients with A/H1N1
inﬂuenza were made a retrospectively investigation in June
2009, the data included the change of body temperature,
blood routine and chest X-rays check, 18 patients with
ordinary inﬂuenza were studied as the control group.
Results: There were not signiﬁcant difference for the
change of body temperature, blood routine (P> 0.05). The
chest X-rays check were normal in the two groups. All
patients were conﬁrmed positive for A/H1N1 RNA when they
had fever, and were negative for A/H1N1 RNA when they
had no fever in the A/H1N1 inﬂuenza group, those patients
with ordinary inﬂuenza were all negative for A/H1N1 RNA
when they had or not fever. These patients with A/H1N1
inﬂuenza or ordinary inﬂuenza had no complications, and
all had good prognosis.
Conclusion: A/H1N1 inﬂuenza did not have any special
clinical manifestations compared with ordinary inﬂuenza.
PP-074 Small interfering RNA (siRNA) mediated
inhibition of inﬂuenza A virus replication in
mammalian cell line
B. Kumar1 *, P. Kumar1, R. Rajput1, M. Khanna1.
1Department of Respiratory Virology, Vallabhbhai Patel
Chest Institute, University of Delhi, India
Background: Inﬂuenza A virus, since time immemorial, has
posed an acute worldwide threat to human health and
has been the cause of frequent epidemics and reoccurring
pandemics. Various RNA interference (RNAi) studies have
been carried out for the RNA-mediated RNA degradation in
a sequence-speciﬁc manner. NS1 gene of inﬂuenza viruses
plays a crucial role in inhibiting the interferon-mediated
responses in the host.
Methods: We have studied the viral replication inhibition
using siRNAs targeted against the conserved regions of the
NS1 gene of inﬂuenza A Virus. The NS1 gene was cloned in
pSecTag 2A vector and was co-transfected with 30, 40 and
50 pmoles of the designed siRNAs in MDCK cells. The same
concentrations of siRNAs were also transfected with the
whole virus (Inﬂuenza A/PR/8/34) to study the inhibition of
replication. RT-PCR and Real-time RT-PCR assays followed
by western blot analysis were performed to detect the
inhibition of the expression of NS1 gene.
Results: All the tests conﬁrmed an increase in inhibition
of the expression of NS1 gene with an increase in the
concentration of siRNA. The maximum inhibition (75%) of
the virus replication was observed at 50 pmoles of siRNA.
Conclusion: Our study demonstrates that siRNA is able to
cleave the target RNA at simulated physiological condition in
a sequence speciﬁc manner. An increase in down-regulation
of the cloned NS1 gene as well as a signiﬁcant protection
against inﬂuenza virus infection in MDCK cells was observed
with an increase in siRNA concentration from 30 50 pm.
The maximum inhibition of gene expression as well as viral
replication inhibition was observed at 50pm concentration
of siRNA.
PP-075 Expression of neuraminidase protein of H1N1
swine-origin inﬂuenza A virus (S-OIV) in insect
cells with a baculovirus expression system
H. Song1,2 *, Q. Wang1, Y. Li1, D. Zhang2, J. Cheng1.
1Department of Infectious Diseases, Beijing Ditan Hospital,
Capital Medical University, Beijing, China, 2College of
Veterinary Medicine, Northwest A&F University, Yangling,
China
Objective: To construct the recombinant baculovirus
expressing 2009 pandemic H1N1 swine-origin inﬂuenza A
virus (S-OIV) Neuraminidase (NA) gene in insect cell.
Methods: The NA gene of Inﬂuenza A virus [A/California/
VRDL98/2009 (H1N1)] was cloned into pGEM-T easy
vector and then was ligated into baculovirus donor
plasmid pFastBacHTa after cutting by EcoRI and
Hind III. pFastBacHTa-NA was subsequently transformed
into DH10Bac E. coli competent cells, which contained the
baculovirus shuttle vector (Bacmid) and the helper plasmid
to generate a recombinant bacmid. The recombinant
baculovirus stock was prepared by transfecting the
recombinant bacmid DNA into the Sf9 insect cell for protein
expression after ampliﬁcation. Sodium dodecyl sulfate-
polyacrylamide gel electrophoresis (SDS-PAGE) and Western
blotting were performed to identify the antigenicity of the
recombinant protein.
